The complete news release.
FEBRUARY 2, 1998
Pyng Medical Receives Ethical Approval for F.A.S.T 1
System
VANCOUVER, BRITISH COLUMBIA--Pyng Technologies Corp. is very proud
to announce that subsidiary Pyng Medical Corp has received Ethical
Approval for the F.A.S.T 1 (TM) System for Intraosseous Infusion
from the University of Maryland Medical Center.
Ethical Approval was required in order to proceed with full field
trial evaluation of the F.A.S.T 1 Intraosseous Infusion System in
live patients, in actual emergency room and pre-hospital
conditions.
The University of Maryland Medical Center (UMMC), one of America's
major trauma centers, has agreed to conduct field trials and be
the central data collection center for the F.A.S.T 1 (TM) System
in the USA.
Pyng Medical Corp is now cleared to proceed with UMMC on live
trials at Maryland as well as many other sites selected for field
trials in the USA and coordinated by UMMC.
This news release follows our recently announced approval from the
Ehtical Review Board of the University of British Columbia,
Canada, to conduct field trials on the F.A.S.T 1 system at St.
Paul's Hospital in Vancouver and Royal Columbian Hospital in New
Westminster.
Pyng Medical Corp. has consistently met the stringent requirements
of both regulatory and ethical approvals necessary to take this
life saving medical device to market. Pyng Medical's Corp.'s
dedicated team is preparing to deliver out the F.A.S.T 1 System
and the training tools as quickly as site visits can be arranged.
Over the last few months Pyng Medical Corp. has achieved,
- Canadian Health Protection Branch approval
- U.S. FDA clearance #K970380
- 24 locations in America, including UMMC, selected for field trials
subject to Ethical Approval (Cleared).
- Canadian Hospitals selected for field trials subject to Ethical
Approval (Cleared)
- Grant for $100,000.00 from the B.C. Science Council for field
trials.
- Full presentation to the US Military at the Special Operations
Medical Association.
- F.A.S.T 1 System featured article in January 1998 issue of Journal
of Emergency Medicine.
disclaimer
FOR FURTHER INFORMATION PLEASE CONTACT:
Pyng Technologies Corp.
Michael W. Jacobs
President
(604) 875-4526
(604) 875-5390 (FAX)
Web Site: www.pyng.com
The VSE has neither approved or reviewed the contents of this news
release.
NEWS RELEASE TRANSMITTED BY CANADIAN CORPORATE NEWS
FOR: PYNG TECHNOLOGIES CORP.
VSE SYMBOL: PYT |
